The GLP-1 RAs Wegovy, Ozempic, Mounjaro, and Zepbound have taken up more real estate on the US map in some areas than others. Click to find out more.
Patient Care Online March 2024
Digital Edition for Patient Care Online for March, 2024
Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.
In an open letter to the public, Lilly decries use of tirzepatide products Mounjaro and Zepbound for nonmedical purposes and warns of counterfeit formulations.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Lerodalcibep Autoinjector for Hypercholesterolemia, Updated Indication
2
Reminders for Primary Care Physicians, Patients Improved Annual Lung Cancer Screening Adherence
3
Avexitide Reduced Hypoglycemic Events in Phase 3 Post-Bariatric Hypoglycemia Trial
4